Be Ready for Remsima SC for Rheumatoid Arthritis
May 2022
You'll see Remsima SC, the first SUBCUTANEOUS biosimilar of Remicade (infliximab), for rheumatoid arthritis (RA).
We're used to IV biosimilars of this TNF blocker...such as Avsola, Inflectra, or Renflexis...for RA, Crohn's, ulcerative colitis, etc.
So far, Remsima SC is only for maintenance of moderate to severe RA in adults on methotrexate...after induction with IV infliximab.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive